Fatty liver? researchers to check uric acid link
NCT ID NCT07053709
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will screen 200 adults with metabolic fatty liver disease (MAFLD) for high uric acid levels. Researchers will measure uric acid and liver function at diagnosis and after 6 months. The goal is to understand how common high uric acid is in these patients and whether it can help guide better management of the disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could show that checking uric acid levels helps manage fatty liver disease and improve quality of life.
- What could go wrong
- This is an observational screening study, not a treatment trial. It will not test any new drug or therapy, so direct patient benefits are uncertain.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERURICEMIA AND MAFLD are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can fatty liver and hepatitis b together harm kidneys? a study digs into the data
- Sleep apnea may signal hidden liver trouble
- Blood protein may reveal hidden nerve damage in diabetes and fatty liver
- Turkey study reveals hidden fatty liver burden in overweight adults
- New study probes why diabetes patients develop fatty liver
- Could a gut antibiotic shrink fatty liver? small trial aims to find out